A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from USC suggests that semaglutide—the drug marketed as Ozempic for diabetes and Wegovy for obesity—may also help reduce alcohol consumption.

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests.